A股異動 | 容百科技(688005.SH)漲逾7% 與寧德時代簽訂戰略合作暨長期供貨協議
格隆匯1月10日丨容百科技(688005.SH)漲逾7%,報125.01元,總市值560億元。容百科技與寧德時代簽訂長期供貨協議,寧德時代預計2022年向公司採購高鎳三元正極材料約10萬噸,2023年至2025年底將公司作為其三元正極第一供應商,並向公司採購不低於一定比例的高鎳三元正極材料。雙方開展新產品技術合作,包括但不限於超高鎳正極材料、尖晶石鎳錳材料、富鋰錳基材料,以及固態電池、鈉離子電池配套材料等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.